The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check the ...
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Several imported fizzy drinks and sweets from America contain banned and illegal ingredients in the UK, according to the ...
This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to ...
Significant Efficacy and No Serious Adverse Effects Observed with CELZ-201PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage ...
Creative Medical Technology (CELZ) announced one-year follow-up data from the AlloStem Type 2 Diabetes pilot study for late-stage patients.
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced ...
5h
News Medical on MSNUVA launches trial to test AI-powered device for diabetes managementFor people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results